Navigation Links
Ferring Donates US$3 Million to the Royal Textile Academy of Bhutan
Date:7/31/2009

SAINT PREX, Switzerland, July 31 /PRNewswire/ -- Frederik Paulsen, Chairman of Ferring Pharmaceuticals, a pharmaceutical company with presence in all major European markets and in the US, announced a US$3 million donation to the Royal Textile Academy of Bhutan. This money will be used to fund the creation and development of a new cultural centre in the Bhutanese capital of Thimphu.

Bhutan is globally renowned for the beauty of its textiles, designed and created along traditional lines by local Bhutanese weavers. The Academy will provide educational programmes, research and exhibitions aimed at both raising the international profile of Bhutanese textiles and improving the livelihood of the weavers who make them.

Speaking at the official presentation of the grant to the Royal Textile Academy, and in the presence of Her Majesty Ashi Sangay Choden Wangchuck, the Queen of Bhutan, Frederik Paulsen said:

"It is the sincere hope of all of us at Ferring that this grant will go some way towards contributing to the future success of the Royal Textile Academy and the future prosperity of Bhutan. The Academy will act as a focal point for both education and a variety of cultural events. It will include a new, state-of-the-art museum, a textile weaving academy and a conservation centre. It is hoped that the Academy will become a destination for tourists as well as students from all over the world. Both marketing and technical assistance will be provided to the weavers of Bhutan."

Her Majesty Ashi Sangay Choden Wangchuck, in response to Frederik Paulsen, said:

"I sincerely thank Dr. Paulsen and Ferring Pharmaceuticals for the great support they have shown to the Academy. This grant will not only benefit the people of Bhutan, especially our weavers, but will also enrich our cultural and economic development. Establishing the Royal Textile Academy is a dream that many of us in Bhutan share. I am confident that with continued support and guidance, we will succeed in creating a dynamic institution that will ensure that the textile arts of Bhutan continue to flourish into the next century."

About Ferring

Ferring Pharmaceuticals is a Swiss-based research driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of endocrinology, gastroenterology, gynaecology, fertility and urology. In recent years Ferring has expanded beyond its traditional European base and has operations in over 40 countries. To learn more about Ferring or its products please visit http://www.ferring.com.


'/>"/>
SOURCE Ferring Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest
2. Ferring Pharmaceuticals EUFLEXXA(TM) to Serve as Sponsor for Sprint Force America Masters Track Club
3. Increase in Diagnostic Imaging Fueled by Self-Referring Doctors
4. Ferring Pharmaceuticals EUFLEXXA(R) to Serve as a Sponsor for the Babolat World Tennis Classic
5. Dr. Jan Linhart Now Offerring Unique Laser Teeth Whitening System
6. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
7. Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer
8. Frost & Sullivan Accolade for Ferring Pharmaceuticals
9. Educating referring clinicians about advanced imaging leads to drop in imaging exams
10. Ferring Pharmaceuticals and RESOLVE: The National Infertility Association Join Together to Launch Nurse Liaison Program
11. ALL: Boston Archdiocese Reportedly on Track for Abortion Referring Venture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... TX (PRWEB) , ... September 20, 2017 , ... ... date of the much-anticipated fall event , Look Awesome This Autumn with ... personalized consultations, special pricing and refreshments. , Mirror Mirror Beauty Boutique is ...
(Date:9/20/2017)... ... September 20, 2017 , ... Announced that Clear Global ... support services market) has entered into an agreement on September 1, 2017 with ... PGSD is the first private Dental School to launch an online, accredited Post ...
(Date:9/20/2017)... ... , ... Compliancy Group is proud to announce that its ... another long-time client pass their Department of Health and Human Services (HHS) Office ... to the help of the Compliancy Group's Audit Response Program™, not a single ...
(Date:9/20/2017)... ... September 20, 2017 , ... In just a short ... has already been receiving positive feedback from customers trying the product for the first ... Daily Brain Booster was developed by neurosurgeon Shawn Moore, MD, for everyone from athletes ...
(Date:9/20/2017)... ... September 20, 2017 , ... Five consumer packaged goods ... market impact in 27 different categories. Nopavera Plus was named to the ... be announced at SupplySide West 2017 during presentations at SupplySide Central on Sept. 27 ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... 2017  For nearly two decades, New Life Agency has been committed ... industry. Today, New Life Agency announces a powerful three-way partnership designed to ... ... ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
(Date:9/7/2017)...   BioLife Solutions , Inc. (NASDAQ: BLFS ... grade cell and tissue hypothermic storage and ... , President and CEO, will be presenting at two investment ... Renshaw 19 th Annual Global Investment Conference on Tuesday, ... time). The conference is being held at the New York ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
Breaking Medicine Technology: